← FDA Drug Approvals (Drugs@FDA)
DOXORUBICIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2026-02-03
Drug application
- FDA Application #
ANDA219881- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXORUBICIN HYDROCHLORIDE
- Generic name
- DOXORUBICIN HYDROCHLORIDE
- Active ingredients
- DOXORUBICIN HYDROCHLORIDE
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- QILU PHARM HAINAN
- Manufacturer
- Sagent Pharmaceuticals
- First approval
- 2026-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown